Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 411

1.

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.

Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM; Perihilar Cholangiocarcinoma Collaboration Group.

Ann Surg Oncol. 2020 Feb 26. doi: 10.1245/s10434-020-08258-3. [Epub ahead of print]

PMID:
32103419
2.

Intraoperative Correction of Liver Deformation Using Sparse Surface and Vascular Features via Linearized Iterative Boundary Reconstruction.

Heiselman JS, Jarnagin WR, Miga MI.

IEEE Trans Med Imaging. 2020 Jan 17. doi: 10.1109/TMI.2020.2967322. [Epub ahead of print]

PMID:
31976882
3.

The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.

Buisman FE, Galjart B, van der Stok EP, Kemeny NE, Balachandran VP, Boerner T, Cercek A, Grünhagen DJ, Jarnagin WR, Kingham TP, Verhoef C, Koerkamp BG, D'Angelica MI.

HPB (Oxford). 2019 Dec 27. pii: S1365-182X(19)33212-5. doi: 10.1016/j.hpb.2019.11.013. [Epub ahead of print]

PMID:
31889627
4.

Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.

Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D'Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF, Allen PJ.

Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003703. [Epub ahead of print]

PMID:
31804389
5.

Histopathological growth patterns and positive margins after resection of colorectal liver metastases.

Nierop PMH, Höppener DJ, van der Stok EP, Galjart B, Buisman FE, Balachandran VP, Jarnagin WR, Kingham TP, Allen PJ, Shia J, Vermeulen PB, Groot Koerkamp B, Grünhagen DJ, Verhoef C, D'Angelica MI.

HPB (Oxford). 2019 Nov 14. pii: S1365-182X(19)30755-5. doi: 10.1016/j.hpb.2019.10.015. [Epub ahead of print]

PMID:
31735649
6.

Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer.

Datta J, Smith JJ, Chatila WK, McAuliffe JC, Kandoth C, Vakiani E, Frankel TL, Ganesh K, Wasserman I, Lipsyc-Sharf M, Guillem J, Nash GM, Paty PB, Weiser MR, Saltz LB, Berger MF, Jarnagin WR, Balachandran V, Kingham TP, Kemeny NE, Cercek A, Garcia-Aguilar J, Taylor BS, Viale A, Yaeger R, Solit DB, Schultz N, D'Angelica MI.

Clin Cancer Res. 2020 Mar 1;26(5):1077-1085. doi: 10.1158/1078-0432.CCR-19-2390. Epub 2019 Nov 12.

PMID:
31719050
7.

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA Jr, Kemeny NE, Jarnagin WR.

JAMA Oncol. 2019 Oct 31. doi: 10.1001/jamaoncol.2019.3718. [Epub ahead of print]

PMID:
31670750
8.

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.

Buisman FE, Grünhagen DJ, Homs MYV, Grootscholten C, Filipe WF, Kemeny NE, Cercek A, D'Angelica MI, Donswijk ML, van Doorn L, Emmering J, Jarnagin WR, Kingham TP, Klompenhouwer EG, Kok NFM, Kuiper MC, Moelker A, Prevoo W, Versleijen MWJ, Verhoef C, Kuhlmann KFD, Groot Koerkamp B.

Ann Surg Oncol. 2019 Dec;26(13):4599-4607. doi: 10.1245/s10434-019-07973-w. Epub 2019 Oct 22.

9.

Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.

Narayan RR, Harris JW, Chou JF, Gönen M, Bao F, Shia J, Allen PJ, Balachandran VP, Drebin JA, Jarnagin WR, Kemeny NE, Kingham TP, D'Angelica MI.

Ann Surg Oncol. 2020 Jan;27(1):188-195. doi: 10.1245/s10434-019-07934-3. Epub 2019 Oct 15.

PMID:
31617122
10.

Lending a hand for laparoscopic distal pancreatectomy: the optimal approach?

Gamboa AC, Aveson VG, Zaidi MY, Lee RM, Jarnagin WR, Allen PJ, Drebin JA, Peter Kingham T, DeMatteo RP, Sarmiento JM, Russell MC, Cardona K, Kooby DA, D'Angelica MI, Maithel SK.

HPB (Oxford). 2019 Oct 7. pii: S1365-182X(19)30719-1. doi: 10.1016/j.hpb.2019.09.007. [Epub ahead of print]

PMID:
31601508
11.

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.

Pulvirenti A, Javed AA, Landoni L, Jamieson NB, Chou JF, Miotto M, He J, Gonen M, Pea A, Tang LH, Nessi C, Cingarlini S, D'Angelica MI, Gill AJ, Kingham TP, Scarpa A, Weiss MJ, Balachandran VP, Samra JS, Cameron JL, Jarnagin WR, Salvia R, Wolfgang CL, Allen PJ, Bassi C.

Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003579. [Epub ahead of print]

PMID:
31567347
12.

Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver.

Velayati S, Erinjeri JP, Brody LA, Ziv E, Boas FE, Brown KT, Covey AM, Getrajdman GI, Solomon SB, Kingham PT, Tap WD, Jarnagin WR, Yarmohammadi H.

Sarcoma. 2019 Sep 3;2019:3060658. doi: 10.1155/2019/3060658. eCollection 2019.

13.

Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion.

Smith JJ, Chatila WK, Sanchez-Vega F, Datta J, Connell LC, Szeglin BC, Basunia A, Boucher TM, Hauser H, Wasserman I, Wu C, Cercek A, Hechtman JF, Madden C, Jarnagin WR, Garcia-Aguilar J, D'Angelica MI, Yaeger R, Schultz N, Kemeny NE.

Cancer Med. 2019 Nov;8(15):6538-6548. doi: 10.1002/cam4.2415. Epub 2019 Sep 10.

14.

Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.

Ayabe RI, Narayan RR, Ruff SM, Wach MM, Lo W, Nierop PMH, Steinberg SM, Ripley RT, Davis JL, Koerkamp BG, D'Angelica MI, Kingham TP, Jarnagin WR, Hernandez JM.

HPB (Oxford). 2020 Jan;22(1):169-175. doi: 10.1016/j.hpb.2019.07.002. Epub 2019 Aug 22.

PMID:
31447392
15.

Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy.

Buisman FE, Galjart B, van der Stok EP, Balachandran VP, Boerner T, Drebin JA, Grünhagen DJ, Jarnagin WR, Kingham TP, Verhoef C, D'Angelica MI, Groot Koerkamp B.

World J Surg. 2020 Mar;44(3):876-886. doi: 10.1007/s00268-019-05121-9.

PMID:
31410513
16.

Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.

Yamashita R, Perrin T, Chakraborty J, Chou JF, Horvat N, Koszalka MA, Midya A, Gonen M, Allen P, Jarnagin WR, Simpson AL, Do RKG.

Eur Radiol. 2020 Jan;30(1):195-205. doi: 10.1007/s00330-019-06381-8. Epub 2019 Aug 7.

PMID:
31392481
17.

CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.

Attiyeh MA, Chakraborty J, McIntyre CA, Kappagantula R, Chou Y, Askan G, Seier K, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ, Iacobuzio-Donahue CA, Simpson AL, Do RK.

Abdom Radiol (NY). 2019 Sep;44(9):3148-3157. doi: 10.1007/s00261-019-02112-1.

PMID:
31243486
18.

Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.

McIntyre CA, Pulvirenti A, Lawrence SA, Seier K, Gonen M, Balachandran VP, Kingham TP, DʼAngelica MI, Drebin JA, Jarnagin WR, Allen PJ.

Pancreas. 2019 Jul;48(6):832-836. doi: 10.1097/MPA.0000000000001342.

PMID:
31210665
19.

Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma.

Wang T, Drill E, Vakiani E, Pak LM, Boerner T, Askan G, Schvartzman JM, Simpson AL, Jarnagin WR, Sigel CS.

Hum Pathol. 2019 Sep;91:19-25. doi: 10.1016/j.humpath.2019.05.002. Epub 2019 May 21.

PMID:
31121195
20.

Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma-still a long way to go.

Doussot A, Jarnagin WR, Azoulay D, Heyd B.

Hepatobiliary Surg Nutr. 2019 Apr;8(2):161-163. doi: 10.21037/hbsn.2018.11.21. No abstract available.

21.

Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution.

Creasy JM, Goldman DA, Gonen M, Dudeja V, O'Reilly EM, Abou-Alfa GK, Cercek A, Harding JJ, Balachandran VP, Drebin JA, Allen PJ, Kingham TP, D'Angelica MI, Jarnagin WR.

HPB (Oxford). 2019 Nov;21(11):1541-1551. doi: 10.1016/j.hpb.2019.03.370. Epub 2019 Apr 23.

PMID:
31027875
22.

Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas.

Wang T, Askan G, Adsay V, Allen P, Jarnagin WR, Memis B, Sigel C, Seven IE, Klimstra DS, Basturk O.

Am J Surg Pathol. 2019 May;43(5):656-661. doi: 10.1097/PAS.0000000000001226.

PMID:
30986801
23.

Abrupt Discontinuation of the Codman Hepatic Artery Infusion Pump: Considerations in the Era of Precision Medicine.

Ellis RJ, Angelos P, Jarnagin WR, Kemeny NE, Merkow RP.

J Am Coll Surg. 2019 Aug;229(2):217-219. doi: 10.1016/j.jamcollsurg.2019.03.002. Epub 2019 Mar 13. No abstract available.

PMID:
30878584
24.

Response to the Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR.

Ann Surg. 2019 Mar;269(3):e34-e35. doi: 10.1097/SLA.0000000000002871. No abstract available.

PMID:
30724808
25.

Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.

Narayan RR, Goldman DA, Gonen M, Reichel J, Huberman KH, Raj S, Viale A, Kemeny NE, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Jarnagin WR, Kingham TP.

Ann Surg Oncol. 2019 Jun;26(6):1824-1832. doi: 10.1245/s10434-019-07201-5. Epub 2019 Jan 31.

PMID:
30706231
26.

Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.

Pak LM, Gagnière J, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Miga MI, Simpson AL, Kingham TP.

J Gastrointest Surg. 2019 Apr;23(4):760-767. doi: 10.1007/s11605-019-04106-2. Epub 2019 Jan 24.

27.

Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study.

Lawrence SA, McIntyre CA, Pulvirenti A, Seier K, Chou Y, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Apr;228(4):595-601. doi: 10.1016/j.jamcollsurg.2018.12.018. Epub 2019 Jan 8.

PMID:
30630087
28.

Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.

Wong W, Lowery MA, Berger MF, Kemel Y, Taylor B, Zehir A, Srinivasan P, Bandlamudi C, Chou J, Capanu M, Varghese A, Yu KH, Iacobuzio-Donahue CA, Shia J, Klimstra DS, Jarnagin WR, Stadler ZK, O'Reilly EM.

Cancer. 2019 May 1;125(9):1441-1448. doi: 10.1002/cncr.31951. Epub 2019 Jan 8.

PMID:
30620386
29.

Fast and accurate vision-based stereo reconstruction and motion estimation for image-guided liver surgery.

Speers AD, Ma B, Jarnagin WR, Himidan S, Simpson AL, Wildes RP.

Healthc Technol Lett. 2018 Oct 19;5(5):208-214. doi: 10.1049/htl.2018.5071. eCollection 2018 Oct.

30.

Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.

Narayan RR, Creasy JM, Goldman DA, Gönen M, Kandoth C, Kundra R, Solit DB, Askan G, Klimstra DS, Basturk O, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Kingham TP, Simpson AL, Abou-Alfa GK, Harding JJ, O'Reilly EM, Butte JM, Matsuyama R, Endo I, Jarnagin WR.

Cancer. 2019 Feb 15;125(4):575-585. doi: 10.1002/cncr.31850. Epub 2018 Nov 14.

31.

Laparoscopic Liver Resection Difficulty Score-a Validation Study.

Lee SY, Goh BKP, Sepideh G, Allen JC, Merkow RP, Teo JY, Chandra D, Koh YX, Tan EK, Kam JH, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, D'Angelica MI, Jarnagin WR, Peter Kingham T, Chan CY.

J Gastrointest Surg. 2019 Mar;23(3):545-555. doi: 10.1007/s11605-018-4036-y. Epub 2018 Nov 12.

PMID:
30421119
32.

Outcomes after Pancreatectomy with Routine Pasireotide Use.

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Feb;228(2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. Epub 2018 Nov 7.

PMID:
30414453
33.

Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):395. doi: 10.1007/s00268-018-4845-x.

PMID:
30406321
34.

Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection.

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Covey AM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Gerdes H, Allen PJ, Schattner MA.

HPB (Oxford). 2019 Apr;21(4):434-443. doi: 10.1016/j.hpb.2018.08.010. Epub 2018 Oct 4.

PMID:
30293867
35.

A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.

Gaspersz MP, Buettner S, Roos E, van Vugt JLA, Coelen RJS, Vugts J, Wiggers JK, Allen PJ, Besselink MG, Busch ORC, Belt EJ, D'Angelica MI, DeMatteo RP, de Jonge J, Kingham TP, Polak WG, Willemssen FEJA, van Gulik TM, Jarnagin WR, Ijzermans JNM, Groot Koerkamp B.

J Surg Oncol. 2018 Sep;118(3):469-476. doi: 10.1002/jso.25174. Epub 2018 Aug 21.

PMID:
30132904
36.

Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.

Attiyeh MA, Chakraborty J, Gazit L, Langdon-Embry L, Gonen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Do RK, Simpson AL.

HPB (Oxford). 2019 Feb;21(2):212-218. doi: 10.1016/j.hpb.2018.07.016. Epub 2018 Aug 7.

37.

A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers.

Olthof PB, Miyasaka M, Koerkamp BG, Wiggers JK, Jarnagin WR, Noji T, Hirano S, van Gulik TM.

HPB (Oxford). 2019 Mar;21(3):345-351. doi: 10.1016/j.hpb.2018.07.014. Epub 2018 Aug 4.

38.

A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection.

Tufts LS, Jarnagin ED, Flynn JR, Gonen M, Guillem JG, Paty PB, Nash GM, Smith JJ, Wei IH, Pappou E, D'Angelica MI, Allen PJ, Peter Kingham T, Balachandran VP, Drebin JA, Garcia-Aguilar J, Jarnagin WR, Weiser MR.

HPB (Oxford). 2019 Feb;21(2):181-186. doi: 10.1016/j.hpb.2018.07.001. Epub 2018 Aug 1.

39.

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.

Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Ventura A.

PLoS One. 2018 Jul 27;13(7):e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018.

40.

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center.

Lidsky ME, Jarnagin WR.

Ann Gastroenterol Surg. 2018 Jun 29;2(4):304-312. doi: 10.1002/ags3.12181. eCollection 2018 Jul. Review.

41.

Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.

Gagnière J, Dupré A, Gholami SS, Pezet D, Boerner T, Gönen M, Kingham TP, Allen PJ, Balachandran VP, De Matteo RP, Drebin JA, Yaeger R, Kemeny NE, Jarnagin WR, D'Angelica MI.

Ann Surg. 2020 Jan;271(1):147-154. doi: 10.1097/SLA.0000000000002968.

PMID:
29995686
42.

"Response to Letter to the Editor: Impact of Recurrence Surveillance on Recurrence Patterns After Resection of Hepatocellular Carcinoma".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR.

Ann Surg. 2018 Jun 28. doi: 10.1097/SLA.0000000000002871. [Epub ahead of print] No abstract available.

PMID:
29958228
43.

Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):385-394. doi: 10.1007/s00268-018-4726-3. Erratum in: World J Surg. 2018 Nov 7;:.

44.

Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.

Creasy JM, Midya A, Chakraborty J, Adams LB, Gomes C, Gonen M, Seastedt KP, Sutton EJ, Cercek A, Kemeny NE, Shia J, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI, Do RKG, Simpson AL.

Eur Radiol. 2019 Jan;29(1):458-467. doi: 10.1007/s00330-018-5542-8. Epub 2018 Jun 19.

45.

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M, Kemeny NE, O'Reilly EM, El-Dika I, Jarnagin WR, Harding JJ, D'Angelica MI, Cercek A, Hechtman JF, Solit DB, Schultz N, Hyman DM, Klimstra DS, Saltz LB, Abou-Alfa GK.

Clin Cancer Res. 2018 Sep 1;24(17):4154-4161. doi: 10.1158/1078-0432.CCR-18-0078. Epub 2018 May 30.

46.

Surgery for perihilar cholangiocarcinoma.

Groot Koerkamp B, Jarnagin WR.

Br J Surg. 2018 Jun;105(7):771-772. doi: 10.1002/bjs.10875. No abstract available.

PMID:
29756647
47.

Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging.

Perrin T, Midya A, Yamashita R, Chakraborty J, Saidon T, Jarnagin WR, Gonen M, Simpson AL, Do RKG.

Abdom Radiol (NY). 2018 Dec;43(12):3271-3278. doi: 10.1007/s00261-018-1600-6.

48.

Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, Deshwar A, Buettner S, Allen PJ, Kingham TP, Pawlik TM, He J, Cameron JL, Jarnagin WR, Wolfgang CL, D'Angelica MI, Weiss MJ.

Br J Surg. 2018 Aug;105(9):1210-1220. doi: 10.1002/bjs.10838. Epub 2018 Apr 25.

PMID:
29691844
49.

Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR.

J Am Coll Surg. 2018 Aug;227(2):238-246.e2. doi: 10.1016/j.jamcollsurg.2018.03.041. Epub 2018 Apr 6.

50.

Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN).

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Basturk O, Klimstra D, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2018 Jun;25(6):1752-1759. doi: 10.1245/s10434-018-6445-2. Epub 2018 Mar 27.

PMID:
29589164

Supplemental Content

Loading ...
Support Center